CP2C9 Polyclonal Antibody, 20ul Fluorescent Staining Unique superhydrophilic surface treatment technology

Unique superhydrophilic surface treatment technology provides better adherence for cells

Acts as a negative regulator of MAP3K3-mediated activation of ERK

particularly on chromosomes Y and 15

Mutations in this gene are associated with an autosomal dominant form of hereditary fibrosing poikiloderma (HFP)

retinal degeneration

CP2C9 Polyclonal Antibody, 20ul Fluorescent Staining Unique superhydrophilic surface treatment technologyThis gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S warfarin. Studies